《诺和诺德Novo Nordisk（NVO）2025年第三季度投资者活动PPT「NYSE」（英文版）（135页）.pdf》由会员分享，可在线阅读，更多相关《诺和诺德Novo Nordisk（NVO）2025年第三季度投资者活动PPT「NYSE」（英文版）（135页）.pdf（135页珍藏版）》请在三个皮匠报告上搜索。

1、Novo Nordisk a focused healthcare companyInvestor presentationFirst nine months of 2025RAFAEL VALVERDERAFAEL VALVERDERafael lives with obesityMexico2Novo NordiskInvestor presentation First nine months of 2025AgendaProgress on Strategic Aspirations 2025FinancialsInnovation and therapeutic focusCommer

2、cial executionAgenda3Novo NordiskInvestor presentation First nine months of 20253Novo Nordisks statutory Annual Report 2024,Form 20-F,any quarterly financial reports,investor presentations and written information released,shown,or oral statements made,to the public in the future by or on behalf of N

3、ovo Nordisk,may contain certain forward-looking statements relating to the operating,financial and sustainability performance and results of Novo Nordisk and/or the industry in which it operates.Forward-looking statements can be identified by the fact that they do not relate to historical or current

4、 facts and include guidance.Words such as believe,expect,may,will,plan,strategy,transition plan,prospect,foresee,estimate,project,anticipate,can,intend,target and other words and terms of similar meaning in connection with any discussion of future operating,financial or sustainability performance id

5、entify forward-looking statements.Examples of such forward-looking statements include,but are not limited to:Statements of targets,future guidance,(transition)plans,objectives or goals for future operations and/or not yet completed business acquisitions or divestments,including those related to oper

6、ating,financial and sustainability matters,Novo Nordisks products,product research,product development,product introductions and product approvals as well as cooperation in relation thereto;Statements containing projections of or targets for revenues,costs,income(or loss),earnings per share,capital